EDITORIAL
Published on 12 Jan 2022
Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
doi 10.3389/fphar.2021.816896
- 1,049 views
- 2 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
48k
Total downloads
174k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 22 Sep 2021
AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway In vitro and In vivo
doi 10.3389/fphar.2021.714365
- 2,342 views
- 12 citations
ORIGINAL RESEARCH
Published on 27 Aug 2021
The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B
doi 10.3389/fphar.2021.720619
- 2,338 views
- 5 citations
ORIGINAL RESEARCH
Published on 08 Jul 2021
The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma
doi 10.3389/fonc.2021.685694
- 2,040 views
- 7 citations
REVIEW
Published on 07 Jul 2021
Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
doi 10.3389/fonc.2021.641522
- 4,181 views
- 31 citations
ORIGINAL RESEARCH
Published on 30 Jun 2021
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
doi 10.3389/fphar.2021.669469
- 3,896 views
- 12 citations
CASE REPORT
Published on 28 Jun 2021
Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation
doi 10.3389/fonc.2021.676092
- 1,399 views
- 2 citations
ORIGINAL RESEARCH
Published on 20 May 2021
lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma
doi 10.3389/fonc.2021.651693
- 2,028 views
- 20 citations
ORIGINAL RESEARCH
Published on 20 May 2021
Maprotiline Suppresses Cholesterol Biosynthesis and Hepatocellular Carcinoma Progression Through Direct Targeting of CRABP1
doi 10.3389/fphar.2021.689767
- 2,518 views
- 13 citations
BRIEF RESEARCH REPORT
Published on 20 May 2021
AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
doi 10.3389/fonc.2021.680663
- 1,980 views
- 8 citations
ORIGINAL RESEARCH
Published on 06 May 2021
Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling
doi 10.3389/fphar.2021.686874
- 2,188 views
- 12 citations
REVIEW
Published on 03 May 2021
Store-Operated Calcium Channels as Drug Target in Gastroesophageal Cancers
doi 10.3389/fphar.2021.668730
- 3,340 views
- 13 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore